Canadian LP Invictus Granted Creditor Protection

Invictus Granted Creditor Protection And Will Commence A Strategic Review

Vancouver, B.C., Feb. 13, 2020 (GLOBE NEWSWIRE) — Invictus MD Strategies Corp. (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) (the “Company”) announced that on Thursday, February 13, 2020, the Supreme Court of British Columbia (the “Court”) issued an order granting the Company’s application for creditor protection under the Companies’ Creditors Arrangement Act (Canada) (“CCAA”). The order also extends protection to Greener Pastures MD Ltd., Acreage Pharms Ltd. (“Acreage”), and 2015059 Alberta Ltd. (together with the Company, the “Invictus Group”).

The Company sought creditor protection for the Invictus Group to stabilize its business, pursue strategic alternatives and address near term liquidity issues as a result of a demand and a notice of intention to enforce security received by Acreage (the primary operating entity of the Invictus Group) from its secured lender ATB Financial. The total amount demanded was $10,618,207.95, together with legal and professional fees, premium, make-whole, costs, charges, disbursements and expenses incurred by ATB Financial.

In accordance with the initial order granted in the CCAA proceedings, ATB Financial, and all other creditors, are stayed from enforcing against the Invictus Group. The Court appointed PricewaterhouseCoopers Inc. to serve as monitor in the CCAA proceedings.

After reviewing a number of options and careful consideration of all available alternatives following thorough consultation with its legal and financial advisors, the Board of Directors of the Company determined that a CCAA proceeding was the most effective way to maximize stakeholder value, to address short-term liquidity challenges and continue to operate the business. While in CCAA protection, the Invictus Group will continue its normal day-to-day operations and plans to commence a review of strategic alternatives in the immediate future.

The Company also announced that Marc Ripa, Interim Chief Executive Officer of the Company, has resigned as Interim Chief Executive Officer and Chief Operating Officer of the Company and any of the Company’s subsidiaries, effective at the close of business on Friday, February 14, 2020. Mr. Ripa will remain as a member of the Company’s Board of Directors to assist with a transition. The Board of Directors of the Company has not yet appointed a replacement for Mr. Ripa as Interim Chief Executive Officer.

The Company intends to provide a further update on these matters when more information is available.

For further information

Harbir Toor

Chief Financial Officer

Phone: 236-788-8134


Investor Relations 1‐844‐800‐6086

E‐Mail: connect@invictus‐

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For more information regarding the Company’s CCAA proceedings

A copy of the Initial Order and other information will be available on the monitor’s website at

Additional enquiries for the monitor may be directed to PricewaterhouseCoopers Inc. in its capacity as Court-appointed monitor of the Invictus Group:

Kiran Chahal

Phone: (604) 806-7787


About Invictus

Invictus is a global cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the Company’s medical clients and retail customers. The Company’s integrated sales approach is defined by five pillars of distribution including medical, adult-use, international, Licensed Producer to Licensed Producer and sales to provinces.

To meet growing demand, Invictus is expanding its cultivation footprint with two cannabis production facilities licensed under the Cannabis Act, which replaced the Access to Cannabis for Medical Purposes Regulations in Canada. Invictus’ wholly-owned subsidiary Acreage Phase I and Phase II facilities are in full production. Acreage has received the amendment to their license from Health Canada to include the west wing of the Phase III facility. AB Laboratories Inc., a company which is a 50% owned subsidiary of Invictus has completed its Phase II expansion and received its amended license from Health Canada. Another of Invictus’ wholly owned subsidiaries, 2015059 Alberta Ltd. (dba Leaf Wise), continues to connect medical clients to physicians for medical cannabis and to Invictus’ fully licensed cannabis producers under the Cannabis Act. Invictus is targeting up to 50 percent of production to medical cannabis. Invictus drives sustainable long-term shareholder value by continuing to develop Invictus’ Canadian production of medical and recreational cannabis products. For more information visit

Original press release

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter